Overview of Dr. Dixon
Dr. Matthew Dixon is a Hepatopancreatobiliary surgeon in Chicago, IL and is affiliated with Rush University Medical Center. He has a passion and interest in the clinical treatment of patients with cancers of the liver, metastatic disease of the liver (such as metastatic colorectal cancer), benign liver tumors, bile duct cancer, pancreatic cancer, pancreatic cysts, neuroendocrine tumors and other types of rare pancreatic tumors.
Office
1725 W Harrison St, Suite 810
Chicago, IL 60614Fax+1 312-563-2775
Education & Training
- Maimonides Medical CenterResidency, Surgery, 2009 - 2014
- St. George's University School of MedicineClass of 2009
Certifications & Licensure
- IL State Medical License 2022 - 2026
- IN State Medical License 2022 - 2025
- PA State Medical License 2018 - 2023
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 29 citationsProcesses of care in the multidisciplinary treatment of gastric cancer: Results of a RAND/UCLA expert panelSavtaj S. Brar, Alyson L. Mahar, Lucy Helyer, Carol Jane Swallow, Calvin Law
JAMA Surgery. 2014-01-01 - 2 citationsNegative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancerDaniel J. Kagedan, F. Frankul, Abraham El-Sedfy, C. McGregor, Maryam Elmi
Current Oncology. 2016-08-08 - 29 citationsA patient-centred approach toward surgical wait times for colon cancer: a population-based analysisAmy Gillis, Matthew Dixon, Andrew M. Smith, Calvin Law, Natalie G. Coburn
Canadian Journal of Surgery. Journal Canadien De Chirurgie. 2014-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: